Ingredient provider Bioiberica (Barcelona, Spain) has actually released a brand-new retail item to resolve atopic dermatitis in dogs and cats. The item is a collar which contains the business’s lipids-based Biosfeen active ingredient for atopic dermatitis. Biosfeen is a sphingolipids active ingredient that is said to increase filaggrin expression. Filaggrin contributes in the skin’s barrier function.
“The collar functions by releasing Bioiberica’s biologically derived skin health ingredients directly onto the pet’s skin, which are then spread across the body through the lipids of the skin,” the business’s news release states.
The item is offered under the name Atopivet Collar. The business calls the item a “world first” due to the fact that it offers family pet owners an option to the standard topical and oral treatments generally recommended to treat pet atopic dermatitis. Instead, the business says, the collar is an easier application.
“Thanks to its dual maintenance and sparing effect, the Atopivet Collar is well equipped to aid in the cyclical nature of atopic dermatitis and help reduce flare-ups,” said Sergi Segarra, Bioiberica’s R&D job supervisor, animal health, in a news release. He said the collar can take a month or 2 to have a result.
The collar is lavender-scented and water resistant. “We recognized the need for an accessible, effective option that gives owners the freedom to choose a noninvasive, practical alternative to traditional oils, creams, and tablets,” included Jordi Flores Garcia, the business’s marketing director, companion-animal department. “While the collar format is a completely new and innovative approach to supporting pets’ skin health, the ingredients within it have already been shown to be an effective aid for skin conditions like atopic dermatitis, giving vets and pet owners alike assurance of its results.”
So far, Atopivet Collar has actually released in the U.S. and Spain. It will launch in Europe quickly, the company says.
